West Orange, N.J.-based RWJBarnabas Health recorded an operating income of $708.9 million (6.4% operating margin) in 2025, up from an operating income of $290.7 million (3% margin) during the same period last year, according to its Feb. 13 financial report.
Total operating revenue was $11 billion for the 12 months ended Dec. 31, up from $9.6 billion in 2024. Total patient service revenue was $10.2 billion, up from $8.9 billion. Inpatient service revenue was $5.2 billion, up from $4.5 billion. Outpatient service revenue was $3.5 billion, up from $3 billion. Professional billing revenue was $1.4 billion, up from $1.2 billion.
Total operating expenses were $10.3 billion in 2025, up from $9.3 billion the prior year. Salaries and benefits totaled $4.7 billion, up from $4.3 billion. The increase was driven by higher labor costs associated with additional full-time equivalent employees and annual merit increases. Supplies and other expenses were $3.7 billion, up from $3.3 billion, driven by higher patient volumes and market changes.
RWJBarnabas reported a net income of $1.5 billion in 2025, up from $992.3 million in 2024.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
